Recall Enforment Report D-1046-2022
- NDC List
- Drug Recall Enforcement Reports
- Recall Enforcement Report: 89646
Multi event Drug Recall Enforcement Report Class II voluntary initiated by Mckesson Medical-Surgical Inc. Corporate Office, originally initiated on 04-13-2022 for the product HydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01 The product was recalled due to cgmp deviations: temperature abuse. The product was distributed nationwide and the recall is currently ongoing.
Recall Enforcement Reports
Recall Number | Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-1046-2022 | 04-13-2022 | 06-15-2022 | Class II | 30 bottles/100 capsules per bottle | HydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1036-2022 | 04-13-2022 | 06-15-2022 | Class II | 8 boxes/12 vials each | MIOSTAT (Carbachol Intraocular Solution, USP) 0.01%, 1.5 mL, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0023-15 | cGMP deviations: Temperature abuse | Ongoing |
D-1025-2022 | 04-13-2022 | 06-15-2022 | Class II | 12 bottles | Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1055-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/100 blisters per carton | Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61 | cGMP deviations: Temperature abuse | Ongoing |
D-1075-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 tubes | Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-0994-2022 | 04-13-2022 | 06-15-2022 | Class II | 45 kits | Miocol-E (acetylcholine chloride intraocular solution) 20 mg/2mL (10 mg/mL), Rx only, Manufacturer: Bausch & Lomb, NDC 24208-539-20 | cGMP deviations: Temperature abuse | Ongoing |
D-1056-2022 | 04-13-2022 | 06-15-2022 | Class II | 3 boxes/100 blisters per box | Metronidazole tablets, USP 250 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-1453-61 | cGMP deviations: Temperature abuse | Ongoing |
D-1018-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/30 pouches each | Albuterol Sulfate Inhalation Solution, 0.021%, 0.63 mg/3mL, packaged in 30 x 3 mL Sterile Unit-Dose Vials, Rx only, MFG: Nephron Pharma, NDC 0487-0301-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1031-2022 | 04-13-2022 | 06-15-2022 | Class II | unknown | Sterile Water for Injection USP, 2000 mL, Rx only, Baxter Healthcare Corp., NDC 0338-0013-06 | cGMP deviations: Temperature abuse | Ongoing |
D-1079-2022 | 04-13-2022 | 06-15-2022 | Class II | 20 cartons/10 vials each | Vecuronium Bromide for Injection, 10 mg (1mg/ mL) vial, 10-count box, Rx only, MFG: Teva Pharma USA, NDC 0703-2914-03 | cGMP deviations: Temperature abuse | Ongoing |
D-1076-2022 | 04-13-2022 | 06-15-2022 | Class II | 56 inhalers | Proair, HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 59310-579-22 | cGMP deviations: Temperature abuse | Ongoing |
D-1022-2022 | 04-13-2022 | 06-15-2022 | Class II | 58 cartons | Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1039-2022 | 04-13-2022 | 06-15-2022 | Class II | 4 bottles/30 tablets per bottle | Naltrexone Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, MFG: Mallinckrodt Inc., NDC 0406-1170-03 | cGMP deviations: Temperature abuse | Ongoing |
D-1120-2022 | 04-13-2022 | 06-15-2022 | Class II | 2 cases | Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58 | cGMP deviations: Temperature abuse | Ongoing |
D-1104-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/10 vials | Pantoprazole Sodium for Injection, 40 mg/vial, 10 single-dose vials, Rx only, MFG: Sandoz Pharma, NDC 0781-3232-95 | cGMP deviations: Temperature abuse | Ongoing |
D-1099-2022 | 04-13-2022 | 06-15-2022 | Class II | 157 kits | Thrombin JMI, Vial 5,000IU 2/diluent, kit, Rx only, MFG: Pfizer NDC 60793-215-05 | cGMP deviations: Temperature abuse | Ongoing |
D-1057-2022 | 04-13-2022 | 06-15-2022 | Class II | 16 cartons/100 blisters packs per carton | Promethazine HCl Tablets, USP, 25 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6461-61 | cGMP deviations: Temperature abuse | Ongoing |
D-1013-2022 | 04-13-2022 | 06-15-2022 | Class II | 55 packs | Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1015-2022 | 04-13-2022 | 06-15-2022 | Class II | 25 kits | Firmagon (degarelix for injection) 80 mg, Maintenance Dose (28 days), packaged in a kit, Rx only, MFG: Ferring Pharmaceuticals Inc., NDC 55566-8303-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1081-2022 | 04-13-2022 | 06-15-2022 | Class II | 49 cartons/6 vials each | Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc., NDC 78670-003-67 | cGMP deviations: Temperature abuse | Ongoing |
D-1119-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 cases | Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09 | cGMP deviations: Temperature abuse | Ongoing |
D-1059-2022 | 04-13-2022 | 06-15-2022 | Class II | 32 cartons/100 blister packs per carton | Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-2725-61 | cGMP deviations: Temperature abuse | Ongoing |
D-1108-2022 | 04-13-2022 | 06-15-2022 | Class II | 31 bottles | Tropicamide Ophthalmic Solution, USP 1%, 3 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131435502 | cGMP deviations: Temperature abuse | Ongoing |
D-1008-2022 | 04-13-2022 | 06-15-2022 | Class II | 799 cartons/1 bottle each | Betadine 5%, Sterile Ophthalmic Prep Solution, (povidine-iodine ophthalmic solution), 1 fl. oz. (30 mL), Rx only, Mfd for: Alcon Surgical Inc., NDC 0065-0411-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1038-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/10 vials per carton | Glucagen (glucagon) for injection, packaged in a 10-count box, (10 vials each containing 1 mg per vial), Rx only, MFG: Boehringer Mannheim, NDC 0597-0053-45 | cGMP deviations: Temperature abuse | Ongoing |
D-1103-2022 | 04-13-2022 | 06-15-2022 | Class II | 2 bottles/500 tablets each | Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1060-2022 | 04-13-2022 | 06-15-2022 | Class II | 780 vials | Medroxyprogesterone acetate injectable suspension, 150 mg/mL, 1 mL single dose vial, Rx only, MFG: NorthStarRx/Teva Pharma USA , NDC 16714-981-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1117-2022 | 04-13-2022 | 06-15-2022 | Class II | 26 cases | Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11 | cGMP deviations: Temperature abuse | Ongoing |
D-1049-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/4 bottles per carton/25 tablets per bottle | Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-Davis, Division of Pfizer Inc., NDC 0071-0418-13 | cGMP deviations: Temperature abuse | Ongoing |
D-1020-2022 | 04-13-2022 | 06-15-2022 | Class II | 96 pouches | Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 25 X 3mL unit-dose vials, Rx only, MFG by: Nephron Pharma, NDC 0487-9501-25 | cGMP deviations: Temperature abuse | Ongoing |
D-1096-2022 | 04-13-2022 | 06-15-2022 | Class II | 2 cartons | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfizer, NDC 0009-3073-03 | cGMP deviations: Temperature abuse | Ongoing |
D-1118-2022 | 04-13-2022 | 06-15-2022 | Class II | 39 cases | Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11 | cGMP deviations: Temperature abuse | Ongoing |
D-1017-2022 | 04-13-2022 | 06-15-2022 | Class II | 187 vials | GlucaGen (glucagon) for injection, 1 mg per vial, single dose kit, Rx only, Manufactured for: Boehringer Mannheim, NDC 0597-0260-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1094-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 bottle/100 tablets | Labetalol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, MFG: Par Pharma, NDC 49884-122-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1098-2022 | 04-13-2022 | 06-15-2022 | Class II | 172 packs/10 per pack | Epinephrine, ABJT 0.1 mg/mL, 10 mL, 20GX1.5 (10 pack), Rx only, MFG: Pfizer, NDC 04094-933-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1106-2022 | 04-13-2022 | 06-15-2022 | Class II | 30 tubes | Triamcinolone Acetonide cream, USP, 0.1% ,15 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0004-15 | cGMP deviations: Temperature abuse | Ongoing |
D-1109-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton | Pilocarpine HCL Ophthalmic Solution, USP 2%, 15 mL, Rx only, MFG: Somerset Therapeutics, Inc., NDC 7006919101 | cGMP deviations: Temperature abuse | Ongoing |
D-1054-2022 | 04-13-2022 | 06-15-2022 | Class II | 108 cartons/50 blisters per carton | Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06 | cGMP deviations: Temperature abuse | Ongoing |
D-1100-2022 | 04-13-2022 | 06-15-2022 | Class II | 14 packs/ 5 per pack | Verapamil HCL, ampule, 2.5 mg/ML 2ML (5/pack), Rx only, MFG: Pfizer, NDC 04094-011-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1063-2022 | 04-13-2022 | 06-15-2022 | Class II | 363 vials | MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1110-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 box | Metoprolol tablets 50 mg, 100-count botte, Rx only, MFG: Sun Pharmaceuticals, NDC 57664-0477-52 | cGMP deviations: Temperature abuse | Ongoing |
D-1080-2022 | 04-13-2022 | 06-15-2022 | Class II | 16 cartons/6 vials each | Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc., NDC 27505-003-67 | cGMP deviations: Temperature abuse | Ongoing |
D-1122-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 cases | Paracentesis/Thoracentises Tray (10/cs) Rx CRFPED, Lidocaine Hydrochloride USP, 1%, 5mL, Rx only, MFG: Becton Dickinson | cGMP deviations: Temperature abuse | Ongoing |
D-1010-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 case | Epidural Tray, Nerve Block Single shot, Rx only, # 182207, MFG: Avanos Medical Sales LLC | cGMP deviations: Temperature abuse | Ongoing |
D-1028-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 tube | Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46 | cGMP deviations: Temperature abuse | Ongoing |
D-1061-2022 | 04-13-2022 | 06-15-2022 | Class II | 885 vials | MethyLPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) single dose vial (NDC 6714-088-01) b) 25-count box (NDC16714-088-25), Rx only, MFG: NorthstarRx/Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-1067-2022 | 04-13-2022 | 06-15-2022 | Class II | 2 inhalers | Levalbuterol Tartrate HFA Inhalation Aerosol, 45 mcg/actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 0591-2927-54 | cGMP deviations: Temperature abuse | Ongoing |
D-1007-2022 | 04-13-2022 | 06-15-2022 | Class II | 16 single dose vials | Sumatriptan Injection, USP, 6mg/0.5 mL, packaged in a box of 5 x 0.5 mL single-dose vials, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0173-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1016-2022 | 04-13-2022 | 06-15-2022 | Class II | 15 boxes | Firmagon (degarelix for injection) 240 mg, Starting Dose, packaged in a kit, Rx only, MFG: Ferring Pharmaceuticals Inc., NDC 55566-8403-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1005-2022 | 04-13-2022 | 06-15-2022 | Class II | 2 cartons/2 single dose vials | Olanzapine single dose vial Lyophilized, 10 mg, Rx only, MFG: Auromedics Pharma LLC, NDC# 55150-0308-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1030-2022 | 04-13-2022 | 06-15-2022 | Class II | 8 cases | Spinal Tray (A4058-25 Spinal Tray 25G Whitacre No Epinephrine), Rx only, Manufacturer: Smiths Medical ASD, Inc., NJ | cGMP deviations: Temperature abuse | Ongoing |
D-1004-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/30 patches | Lidocaine Patch, 5%, 30-count box, Rx only, Manufacturer: Rhodes Pharmaceuticals, NDC 42858-0118-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1003-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 cartons/2 ml single dose vials | Dexmedetomidine HCL Single Dose Vial 200 mcg per 2 mL (100mcg/mL), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0209-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1114-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton | Ofloxacin Otic Solution 0.3%, 5 mL bottle, Rx only, MFG: Amneal/Akyma Pharmaceuticals, NDC 69238-1615-3 | cGMP deviations: Temperature abuse | Ongoing |
D-1047-2022 | 04-13-2022 | 06-15-2022 | Class II | 23 tubes | Lidocaine and Prilocaine Cream, 2.5%/2.5%, 5 gram tubes, Rx only, MFG: Sandoz Pharma, NDC 0168-0357-56 | cGMP deviations: Temperature abuse | Ongoing |
D-1066-2022 | 04-13-2022 | 06-15-2022 | Class II | 63 bottles/100 count | Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottle, Rx only, MFG: Teva/Actavis, NDC 00228-2127-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1070-2022 | 04-13-2022 | 06-15-2022 | Class II | 983 cartons/1 vial each and 107 cartons/25 vials each | MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-1111-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/9 blister packs | Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69 | cGMP deviations: Temperature abuse | Ongoing |
D-1064-2022 | 04-13-2022 | 06-15-2022 | Class II | MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-473-01 | cGMP deviations: Temperature abuse | Ongoing | |
D-1089-2022 | 04-13-2022 | 06-15-2022 | Class II | 51 vials | Celestone Soluspan (betamethasone sodium phosphate and betametasone acetate injectable suspension 6 mg/mL, 30 mg/5mL, multidose vial, Rx only, MFG: Merck Company, NDC 0085-4320-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1097-2022 | 04-13-2022 | 06-15-2022 | Class II | 177 cartons | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC# 0009-3475-01), b) 25-count box (NDC 0009-3475-03), Rx only, MFG: Pfizer | cGMP deviations: Temperature abuse | Ongoing |
D-1000-2022 | 04-13-2022 | 06-15-2022 | Class II | 34 cartons/ 25 vials each | Bupivacaine HCl Injection, Multi dose vial, 0.25%, 50 mL/2.5 mg/mL, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0249-50 | cGMP deviations: Temperature abuse | Ongoing |
D-1107-2022 | 04-13-2022 | 06-15-2022 | Class II | 44 bottles | Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile, 0.1%, 10 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131462810 | cGMP deviations: Temperature abuse | Ongoing |
D-1032-2022 | 04-13-2022 | 06-15-2022 | Class II | 3 bottles | Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50 | cGMP deviations: Temperature abuse | Ongoing |
D-1026-2022 | 04-13-2022 | 06-15-2022 | Class II | 21 bottles | Aparaclonidine Ophthalmic Solution 0.5% as base, 0.5%, 5 mL bottle, Rx only, MFG:Sandoz Pharma, NDC 61314-665-05 | cGMP deviations: Temperature abuse | Ongoing |
D-1045-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 tube | Hydrocortisone Ointment USP, 2.5%, NET WT 28.35 g (1 oz) tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0146-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1073-2022 | 04-13-2022 | 06-15-2022 | Class II | 1088 cartons/1 vial each and 63 cartons/25 vials each | MethyLPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0051-01) b) 25-count box (NDC 0703-0051-04), Rx only, MFG: Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-1006-2022 | 04-13-2022 | 06-15-2022 | Class II | 18 vials | Arzol (Silver Nitrate Applicator), (Silver Nitrate 75%, Potassium Nitrate 25%), 100-count box, Rx only, Manufacturer: Arzol Chemical Co, NDC 12870-0001-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1065-2022 | 04-13-2022 | 06-15-2022 | Class II | 6 tubes | Ketoconazole Cream, 2%, Net Wt 60 grams tube, Rx only, MFG: Nycomed Inc, NDC 0168-0099-60 | cGMP deviations: Temperature abuse | Ongoing |
D-1105-2022 | 04-13-2022 | 06-15-2022 | Class II | 50 bottles | Prednisolone Acetate Ophthalmic Suspension, USP 1%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-637-05 | cGMP deviations: Temperature abuse | Ongoing |
D-1050-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 vial | Xylocaine - MPF (lidocaine HCl and epinephrine injection, USP), 1%, 300 mg/30 mL, single dose vial, 5-count box, Rx only, MFG: App Pharmaceuticals LLC, NDC 63323-0487-31 | cGMP deviations: Temperature abuse | Ongoing |
D-1115-2022 | 04-13-2022 | 06-15-2022 | Class II | 122 cartons | Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1021-2022 | 04-13-2022 | 06-15-2022 | Class III | 56 pouches | Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-0201-03), b) 60-count (NDC 0487-0201-60), Rx only, MFG: Nephron Pharma | cGMP deviations: Temperature abuse | Ongoing |
D-1002-2022 | 04-13-2022 | 06-15-2022 | Class II | 32 cartons/25 vials each | Bupivacaine HCl Injection, Single Dose Vial, 0.75%, 10 mL/7.5 mg/mL, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0171-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1091-2022 | 04-13-2022 | 06-15-2022 | Class II | 9 vials | Duraclon (clonidine HCl injection, USP), 1000 mcg/10 mL (100 mcg/mL), 10 mL single-dose vial, Rx only, MFG: Mylan Pharma, NDC 67457-218-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1040-2022 | 04-13-2022 | 06-15-2022 | Class II | 57 pouches | Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25 | cGMP deviations: Temperature abuse | Ongoing |
D-1001-2022 | 04-13-2022 | 06-15-2022 | Class II | 16 cartons/24 vials each | Bupivacaine HCl Injection, Multi dose vial, 0.50%, 50 mL/5 mg/mL, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0250-50 | cGMP deviations: Temperature abuse | Ongoing |
D-1029-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 bottle | Ciprofloxacin Ophthalmic Solution 0.3%, 10 mL bottle, Rx only, Manufactured by: Alcon Laboratories, Inc., NDC 61314-0656-10 | cGMP deviations: Temperature abuse | Ongoing |
D-0996-2022 | 04-13-2022 | 06-15-2022 | Class II | 24 bottles | Topex (benzocaine 20%), Topical Anesthetic Gel Strawberry, 1 oz, Rx only, Manufacturer: DS Healthcare, NDC 0699-5116-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1116-2022 | 04-13-2022 | 06-15-2022 | Class II | 46 cartons | Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29 | cGMP deviations: Temperature abuse | Ongoing |
D-1121-2022 | 04-13-2022 | 06-15-2022 | Class II | 4 cases | Biopsy and Aspiration Tray Bone Marrow Illinois 11GX4 (10/cs) Rx CRFPED Lidocaine Hydrochloride USP, 1%, 5mL, Rx only, MFG: Becton Dickinson | cGMP deviations: Temperature abuse | Ongoing |
D-1043-2022 | 04-13-2022 | 06-15-2022 | Class II | 3 cartons/30 pouches per carton | Lidocaine Patch 5%, 30-count carton, Rx only, MFG: Qualitest Products, NDC 0603-1880-16 | cGMP deviations: Temperature abuse | Ongoing |
D-1077-2022 | 04-13-2022 | 06-15-2022 | Class II | 31 cartons/10 & 25 vials each | Propofol Injectable Emulsion, USP, 200 mg/ 20 mL (10 mg/mL), packaged in a) 50 mL vial, in packs of 20 (NDC 00591-2136-51), b) 100 mL vial, in packs of 10 (NDC 00591-2136-68), Rx only, MFG: Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-1113-2022 | 04-13-2022 | 06-15-2022 | Class II | 43 cartons/12 blister packs | Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottle, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0741-14 | cGMP deviations: Temperature abuse | Ongoing |
D-1033-2022 | 04-13-2022 | 06-15-2022 | Class II | 13 bottles | BSS Sterile Irrigating Solution (balanced salt solution), 15 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-15 | cGMP deviations: Temperature abuse | Ongoing |
D-1083-2022 | 04-13-2022 | 06-15-2022 | Class II | 56 cartons/10 patches each | Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG: Baxter Healthcare Corp, NDC 10019-553-03 | cGMP deviations: Temperature abuse | Ongoing |
D-1101-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 case/100 unit dose cups | Diphenhydramine HCl oral solution, USP, 25 mg/10 mL UD, packaged in a) 10 mL unit dose cups (NDC 0121-0978-10), b) 100-count box (NDC 0121-0978-00), Rx only, MFG: Pharmaceutical Associates Inc. | cGMP deviations: Temperature abuse | Ongoing |
D-1034-2022 | 04-13-2022 | 06-15-2022 | Class II | 4 bottles | BSS Sterile Irrigating Solution (balanced salt solution), 500 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-50 | cGMP deviations: Temperature abuse | Ongoing |
D-1014-2022 | 04-13-2022 | 06-15-2022 | Class II | 30 packs | Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma NDC 49502-101-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1102-2022 | 04-13-2022 | 06-15-2022 | Class II | 120 tubes | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631-36 | cGMP deviations: Temperature abuse | Ongoing |
D-1044-2022 | 04-13-2022 | 06-15-2022 | Class II | 7 bottles | Ciprofloxacin Ophthalmic Solution 0.3%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-656-05 | cGMP deviations: Temperature abuse | Ongoing |
D-0995-2022 | 04-13-2022 | 06-15-2022 | Class II | 3 tubes | TobraDex (tobramycin and dexamethasone), Ophthalmic Ointment, 3.5 gm, Rx only, Manufacturer: Novartis, NDC 0078-0876-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1019-2022 | 04-13-2022 | 06-15-2022 | Class II | 23 pouches | Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 5 x 3 mL unit-dose vials, Rx only, Manufactured by: Nephron Pharma, NDC 0487-9501-03 | cGMP deviations: Temperature abuse | Ongoing |
D-1086-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 case | Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP), packaged in: Twenty-four 30 mL single dose bottles, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0445-35 | cGMP deviations: Temperature abuse | Ongoing |
D-0999-2022 | 04-13-2022 | 06-15-2022 | Class II | 4 cartons/25 vials each | Bupivacaine HCl Injection, single dose vial, 0.5%, 30 mL/5 mg/mL, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0170-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1058-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 bottle/1000 tablets per bottle | Sodium Bicarbonate Tablets, 600 mg, 1000-count bottle, MFG: Major Pharma, NDC 0536-1047-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1062-2022 | 04-13-2022 | 06-15-2022 | Class II | 263 vials | MethyLPREDNISolone Acetate Injectable Suspension, USP, 200 mg/5 mL (40 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA , NDC 16714-089-01 | cGMP deviations: Temperature abuse | Ongoing |
D-0998-2022 | 04-13-2022 | 06-15-2022 | Class II | 224 cartons/10 vials each | Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-169-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1090-2022 | 04-13-2022 | 06-15-2022 | Class II | 22 inhalers | Proventil HFA, (Albuterol Sulfate Inhalation Aerosol), 200 metered inhalations, Rx only, MFG: Merck Company, NDC 0085-1132-04 | cGMP deviations: Temperature abuse | Ongoing |
D-1011-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton | Dihydroergotamine Mesylate, Injection, USP, 1mg/mL, packaged in box of 5 x 1 mL ampules, Rx only, Manufactured for: Perrigo, Minneapolis, MN, NDC 0574-0850-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1082-2022 | 04-13-2022 | 06-15-2022 | Class II | 110 cartons/5000 units each | Recothrom Thrombin Topical (Recombinant), 5,000 units, packaged in a box containing a 5000-unit vial of RECOTHROM with a 5-mL prefilled diluent syringe (containing sterile 0.9% sodium chloride, USP), a sterile needle-free transfer device, a 5-mL sterile empty syringe, and a pre-printed label, Rx only, MFG: Baxter, NDC# 0338-0322-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1024-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 aerosol | Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by: Sandoz Inc., NDC 0781-7296-85 | cGMP deviations: Temperature abuse | Ongoing |
D-0997-2022 | 04-13-2022 | 06-15-2022 | Class II | 13 carton/10 vials each | Azithromycin for Injection USP Vial, 500 mg per vial, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-174-10 | cGMP deviations: Temperature abuse | Ongoing |
D-1078-2022 | 04-13-2022 | 06-15-2022 | Class II | 564 cartons/25 vials each | Propofol Injectable Emulsion, USP 200 mg per 20 mL (10 mg per mL), twenty-five 20 mL vials, Rx only, MFG: Teva Pharma USA, NDC 0591-2136-95 | cGMP deviations: Temperature abuse | Ongoing |
D-1035-2022 | 04-13-2022 | 06-15-2022 | Class II | 13 bottles | Isopto Atropine (atropine sulfate ophthalmic solution) 1%, 5mL bottle, MFG: Alcon Surgical, NDC 0065-0303-55 | cGMP deviations: Temperature abuse | Ongoing |
D-1093-2022 | 04-13-2022 | 06-15-2022 | Class II | 8 bottles/100 tablets each | Prazosin Hydrochloride Capsules, USP, 1 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-1101-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1041-2022 | 04-13-2022 | 06-15-2022 | Class II | 240 cartons/3 blister packs per carton | ClomiPHENE Citrate Tablets, USP 50 mg, 30-count bottle, Rx only, MFG: PAR Pharma, NDC 49884-701-55 | cGMP deviations: Temperature abuse | Ongoing |
D-1068-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/30 pouches | Lidocaine Patch 5%, 30-count box, Rx only, MFG: Teva Pharma USA, NDC 0591-3525-30 | cGMP deviations: Temperature abuse | Ongoing |
D-1027-2022 | 04-13-2022 | 06-15-2022 | Class II | 29 boxes | Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06 | cGMP deviations: Temperature abuse | Ongoing |
D-1087-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 boxes | Kinevac (Sincalide for Injection), 5mcg per vial, 10 vials per box, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0556-15 | cGMP deviations: Temperature abuse | Ongoing |
D-1042-2022 | 04-13-2022 | 06-15-2022 | Class II | 30 cartons/3 blister packs per carton | Olanzapine Orally Disintegrating Tablets, USP 10 mg, 30-count box unit dose tablets (3 blister cards each containing 10 tablets), Rx only, MFG: PAR PHARMA, NDC 49884-321-55 | cGMP deviations: Temperature abuse | Ongoing |
D-1072-2022 | 04-13-2022 | 06-15-2022 | Class II | 796 cartons/1 vial each | MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0045-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1084-2022 | 04-13-2022 | 06-15-2022 | Class II | 19 cases | E-Z-HD (Barium Sulfate for Oral Suspension), 98% w/w, 340 g bottle, Rx only, MFG: Bracco Diagnostics Inc., NDC 32909-764-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1095-2022 | 04-13-2022 | 06-15-2022 | Class II | 30 vials | Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1112-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 carton/10 vials | Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83 | cGMP deviations: Temperature abuse | Ongoing |
D-1069-2022 | 04-13-2022 | 06-15-2022 | Class II | 89 cartons/25 vials per carton and 3 cartons/1 vial | Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA | cGMP deviations: Temperature abuse | Ongoing |
D-1052-2022 | 04-13-2022 | 06-15-2022 | Class II | 76 trays/25 vials per tray | Xylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL, 25-count box (NDC 63323-482-57), Rx only, MFG: Fresenius Kabi USA LLC | cGMP deviations: Temperature abuse | Ongoing |
D-1085-2022 | 04-13-2022 | 06-15-2022 | Class II | 16 boxes/50 pouches per box | E-Z-Gas II, Effervescent Granules, Net Weight: 4 g, 50 packets per box, MFG: Bracco Diagnostics Inc., NDC 0270-9020-01 (discontinued), NDC 10361-793-01 (current) | cGMP deviations: Temperature abuse | Ongoing |
D-1037-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 box/50 blister packs per box | Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15 | cGMP deviations: Temperature abuse | Ongoing |
D-1051-2022 | 04-13-2022 | 06-15-2022 | Class II | 13 syringes | Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial Diluent for Glucagon, 1ml syringe, Rx only, MFG: Eli Lilly, NDC 0002-8031-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1023-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 aerosols | Albuterol Sulfate Inhalation Aerosol HFA with Dose Indicator, 90 mcg, 200 metered inhalations, Rx only, Manufactured for: PAR Pharmaceutical, NDC 0254-1007-52 | cGMP deviations: Temperature abuse | Ongoing |
D-1092-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 bottle/100 capsules | Loperamide Hydrochloride capsules, USP, 2 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-2100-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1053-2022 | 04-13-2022 | 06-15-2022 | Class II | 33 trays/25 vials per tray | Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27 | cGMP deviations: Temperature abuse | Ongoing |
D-1048-2022 | 04-13-2022 | 06-15-2022 | Class II | 7 tubes | Metronidazole Vaginal Gel USP, 0.75% with 5 applicators, Net Wt. 70 g tube, Rx only, MFG: Sandoz, NDC 0781-7077-87 | cGMP deviations: Temperature abuse | Ongoing |
D-1088-2022 | 04-13-2022 | 06-15-2022 | Class II | 1 box/100 blisters packs per box | Levofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61 | cGMP deviations: Temperature abuse | Ongoing |
D-1009-2022 | 04-13-2022 | 06-15-2022 | Class II | 10 cartons/10 vials each | Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 55150-113-10 | cGMP deviations: Temperature abuse | Ongoing |
D-0993-2022 | 04-13-2022 | 06-15-2022 | Class II | 5 cartons | EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1071-2022 | 04-13-2022 | 06-15-2022 | Class II | 65 cartons/1 vial each | MethyLPREDNISolone Acetate Injectable Suspension, USP, 200mg/5mL (40 mg/mL), 5 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0043-01 | cGMP deviations: Temperature abuse | Ongoing |
D-1012-2022 | 04-13-2022 | 06-15-2022 | Class II | 4 cartons/2 auto injectors each | EPI-Pen Jr, 2-PAK, (epinephrine injection, USP) Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-501-02 | cGMP deviations: Temperature abuse | Ongoing |
D-1074-2022 | 04-13-2022 | 06-15-2022 | Class II | 816 cartons/1 vial each | MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5mL (80 mg/mL), 5 mL multi-dose vials, Rx only, MFG: Teva Pharma USA, NDC 0703-0063-01 | cGMP deviations: Temperature abuse | Ongoing |
Recalled Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0002-8031 | Glucagon | Glucagon | Kit | Eli Lilly And Company | Human Prescription Drug | |
0009-3073 | Depo-medrol | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Pharmacia & Upjohn Company Llc | Human Prescription Drug |
0009-3073 | Depo-medrol | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Pharmacia & Upjohn Company Llc | Human Prescription Drug |
0009-3475 | Depo-medrol | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Pharmacia & Upjohn Company Llc | Human Prescription Drug |
0009-3475 | Depo-medrol | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Pharmacia & Upjohn Company Llc | Human Prescription Drug |
0049-0052 | Geodon | Ziprasidone Hydrochloride | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0054 | Geodon | Ziprasidone Hydrochloride | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0056 | Geodon | Ziprasidone Hydrochloride | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0058 | Geodon | Ziprasidone Hydrochloride | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0352 | Geodon | Ziprasidone | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0356 | Geodon | Ziprasidone | Capsule | Oral | Roerig | Human Prescription Drug |
0049-0358 | Geodon | Ziprasidone | Capsule | Oral | Roerig | Human Prescription Drug |
0049-3920 | Geodon | Ziprasidone Mesylate | Injection, Powder, Lyophilized, For Solution | Intramuscular | Roerig | Human Prescription Drug |
0065-0023 | Miostat | Carbachol | Solution | Ophthalmic | Alcon Laboratories, Inc. | Human Prescription Drug |
0065-0303 | Isopto Atropine | Atropine Sulfate | Solution | Ophthalmic | Alcon Laboratories, Inc. | Human Prescription Drug |
0065-0411 | Betadine | Povidone-iodine | Solution | Ophthalmic | Alcon Laboratories, Inc. | Human Prescription Drug |
0065-0741 | Tetracaine Hydrochloride | Tetracaine Hydrochloride | Solution | Ophthalmic | Alcon Laboratories, Inc. | Human Prescription Drug |
0065-0795 | Bss | Balanced Salt Solution | Solution | Ophthalmic | Alcon Laboratories, Inc. | Human Prescription Drug |
0071-0417 | Nitrostat | Nitroglycerin | Tablet | Sublingual | Parke-davis Div Of Pfizer Inc | Human Prescription Drug |
0071-0418 | Nitrostat | Nitroglycerin | Tablet | Sublingual | Parke-davis Div Of Pfizer Inc | Human Prescription Drug |
0071-0419 | Nitrostat | Nitroglycerin | Tablet | Sublingual | Parke-davis Div Of Pfizer Inc | Human Prescription Drug |
0078-0876 | Tobradex | Tobramycin And Dexamethasone | Ointment | Ophthalmic | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0093-1010 | Mupirocin | Mupirocin | Ointment | Topical | Teva Pharmaceuticals Usa, Inc. | Human Prescription Drug |
0121-0489 | Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride | Solution | Oral | Pharmaceutical Associates, Inc. | Human Prescription Drug |
0121-0978 | Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride | Solution | Oral | Pharmaceutical Associates, Inc. | Human Prescription Drug |
0168-0002 | Triamcinolone Acetonide | Triamcinolone Acetonide | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0003 | Triamcinolone Acetonide | Triamcinolone Acetonide | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0004 | Triamcinolone Acetonide | Triamcinolone Acetonide | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0055 | Betamethasone Dipropionate | Betamethasone Dipropionate | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0056 | Betamethasone Dipropionate | Betamethasone Dipropionate | Ointment | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0057 | Betamethasone Dipropionate | Betamethasone Dipropionate | Lotion | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0080 | Hydrocortisone | Hydrocortisone | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0099 | Ketoconazole | Ketoconazole | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0146 | Hydrocortisone | Hydrocortisone | Ointment | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0168-0357 | Lidocaine And Prilocaine | Lidocaine And Prilocaine | Cream | Topical | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc. | Human Prescription Drug |
0185-0615 | Hydroxyzine Pamoate | Hydroxyzine Pamoate | Capsule | Oral | Eon Labs, Inc. | Human Prescription Drug |
0185-0674 | Hydroxyzine Pamoate | Hydroxyzine Pamoate | Capsule | Oral | Eon Labs, Inc. | Human Prescription Drug |
0185-0676 | Hydroxyzine Pamoate | Hydroxyzine Pamoate | Capsule | Oral | Eon Labs, Inc. | Human Prescription Drug |
0264-3103 | Cefazolin Sodium | Cefazolin Sodium | Solution | Intravenous | B. Braun Medical Inc. | Human Prescription Drug |
0264-3105 | Cefazolin Sodium | Cefazolin Sodium | Solution | Intravenous | B. Braun Medical Inc. | Human Prescription Drug |
0270-0445 | Gastrografin | Diatrizoate Meglumine And Diatrizoate Sodium | Liquid | Oral; Rectal | Bracco Diagnostics Inc | Human Prescription Drug |
0270-0556 | Kinevac | Sincalide | Injection, Powder, Lyophilized, For Solution | Intravenous | Bracco Diagnostics Inc. | Human Prescription Drug |
0338-0013 | Sterile Water | Water | Injection, Solution | Intravenous | Baxter Healthcare Company | Human Prescription Drug |
0338-0322 | Recothrom | Thrombin Topical Recombinant | Kit | Baxter Healthcare Corporation | Human Prescription Drug | |
0338-0326 | Recothrom | Thrombin Topical Recombinant | Kit | Baxter Healthcare Corporation | Human Prescription Drug | |
0338-0330 | Recothrom | Thrombin Topical Recombinant | Kit | Baxter Healthcare Corporation | Human Prescription Drug | |
0338-0519 | Intralipid | I.v. Fat Emulsion | Emulsion | Intravenous | Baxter Healthcare Corporation | Human Prescription Drug |
0338-0519 | Intralipid | I.v. Fat Emulsion | Emulsion | Intravenous | Baxter Healthcare Corporation | Human Prescription Drug |
0378-1101 | Prazosin Hydrochloride | Capsule | Mylan Pharmaceuticals Inc. | Drug For Further Processing | ||
0378-1101 | Prazosin Hydrochloride | Prazosin Hydrochloride | Capsule | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0378-2100 | Loperamide Hydrochloride | Loperamide Hydrochloride | Capsule | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0378-2302 | Prazosin Hydrochloride | Capsule | Mylan Pharmaceuticals Inc. | Drug For Further Processing | ||
0378-2302 | Prazosin Hydrochloride | Prazosin Hydrochloride | Capsule | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0378-3205 | Prazosin Hydrochloride | Capsule | Mylan Pharmaceuticals Inc. | Drug For Further Processing | ||
0378-3205 | Prazosin Hydrochloride | Prazosin Hydrochloride | Capsule | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0406-1170 | Naltrexone Hydrochloride | Naltrexone Hydrochloride | Tablet, Film Coated | Oral | Specgx Llc | Human Prescription Drug |
0409-1159 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1159 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1160 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Infiltration; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1162 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1162 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1163 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Perineural | Hospira, Inc. | Human Prescription Drug |
0409-1165 | Bupivacaine Hydrochloride | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Retrobulbar | Hospira, Inc. | Human Prescription Drug |
0409-9042 | Bupivacaine Hydrochloride And Epinephrine | Bupivacaine Hydrochloride And Epinephrine | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-9043 | Bupivacaine Hydrochloride And Epinephrine | Bupivacaine Hydrochloride And Epinephrine | Injection, Solution | Infiltration; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-9045 | Bupivacaine Hydrochloride And Epinephrine | Bupivacaine Hydrochloride And Epinephrine | Injection, Solution | Epidural; Intracaudal; Perineural | Hospira, Inc. | Human Prescription Drug |
0409-9046 | Bupivacaine Hydrochloride And Epinephrine | Bupivacaine Hydrochloride And Epinephrine | Injection, Solution | Perineural | Hospira, Inc. | Human Prescription Drug |
0487-0201 | Ipratropium Bromide And Albuterol Sulfate | Ipratropium Bromide And Albuterol Sulfate | Solution | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | Human Prescription Drug |
0487-0301 | Albuterol Sulfate | Albuterol Sulfate | Solution | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | Human Prescription Drug |
0487-9501 | Albuterol Sulfate | Albuterol Sulfate | Solution | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | Human Prescription Drug |
0487-9801 | Ipratropium Bromide | Ipratropium Bromide | Solution | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | Human Prescription Drug |
0487-9904 | Albuterol Sulfate | Albuterol Sulfate | Solution | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | Human Prescription Drug |
0536-1047 | Sodium Bicarbonate Antacid | Sodium Bicarbonate | Tablet | Oral | Rugby Laboratories | Human Otc Drug |
0574-0850 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | Injection, Solution | Intramuscular; Intravenous; Subcutaneous | Padagis Us Llc | Human Prescription Drug |
0591-2136 | Propofol | Propofol | Injection, Emulsion | Intravenous | Actavis Pharma, Inc. | Human Prescription Drug |
0591-2927 | Levalbuterol Tartrate Hfa Inhalation | Levalbuterol Tartrate | Aerosol, Metered | Oral | Actavis Pharma, Inc. | Human Prescription Drug |
0597-0053 | Glucagen | Glucagon Hydrochloride | Injection, Powder, For Solution | Intramuscular; Intravenous; Subcutaneous | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug |
0597-0260 | Glucagen | Glucagon Hydrochloride | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug | |
0603-1880 | Lidocaine | Lidocaine | Patch | Cutaneous | Par Pharmaceutical | Human Prescription Drug |
0703-0031 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-0043 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-0045 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-0051 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-0063 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-2914 | Vecuronium Bromide | Vecuronium Bromide | Injection, Powder, Lyophilized, For Solution | Intravenous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-6801 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | Injection, Suspension | Intramuscular | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0781-2020 | Amoxicillin | Amoxicillin | Capsule | Oral | Sandoz Inc | Human Prescription Drug |
0781-2321 | Aprepitant | Aprepitant | Capsule | Oral | Sandoz Inc | Human Prescription Drug |
0781-2322 | Aprepitant | Aprepitant | Capsule | Oral | Sandoz Inc | Human Prescription Drug |
0781-2323 | Aprepitant | Aprepitant | Capsule | Oral | Sandoz Inc | Human Prescription Drug |
0781-2613 | Amoxicillin | Amoxicillin | Capsule | Oral | Sandoz Inc | Human Prescription Drug |
0781-3232 | Pantoprazole Sodium | Pantoprazole Sodium | Injection, Powder, For Solution | Intravenous | Sandoz Inc | Human Prescription Drug |
0781-4063 | Aprepitant | Aprepitant | Kit | Sandoz Inc | Human Prescription Drug | |
0781-5060 | Amoxicillin | Amoxicillin | Tablet, Film Coated | Oral | Sandoz Inc | Human Prescription Drug |
0781-5061 | Amoxicillin | Amoxicillin | Tablet, Film Coated | Oral | Sandoz Inc | Human Prescription Drug |
0781-6039 | Amoxicillin | Amoxicillin | Powder, For Suspension | Oral | Sandoz Inc | Human Prescription Drug |
0781-6041 | Amoxicillin | Amoxicillin | Powder, For Suspension | Oral | Sandoz Inc | Human Prescription Drug |
0781-6156 | Amoxicillin | Amoxicillin | Powder, For Suspension | Oral | Sandoz Inc | Human Prescription Drug |
0781-6157 | Amoxicillin | Amoxicillin | Powder, For Suspension | Oral | Sandoz Inc | Human Prescription Drug |
0781-7077 | Metronidazole | Metronidazole | Gel | Vaginal | Sandoz Inc. | Human Prescription Drug |
0781-7296 | Albuterol Sulfate | Albuterol Sulfate | Aerosol, Metered | Respiratory (inhalation) | Sandoz Inc | Human Prescription Drug |
0904-0430 | Doxycycline | Doxycycline Hyclate | Tablet, Coated | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-1453 | Metronidazole | Metronidazole | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-2725 | Sulfamethoxazole And Trimethoprim | Sulfamethoxazole And Trimethoprim | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-5853 | Ibuprofen | Ibuprofen | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-5854 | Ibuprofen | Ibuprofen | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-5855 | Ibuprofen | Ibuprofen | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-6351 | Levofloxacin | Levofloxacin | Tablet, Film Coated | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-6352 | Levofloxacin | Levofloxacin | Tablet, Film Coated | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-6353 | Levofloxacin | Levofloxacin | Tablet, Film Coated | Oral | Major Pharmaceuticals | Human Prescription Drug |
0904-6461 | Promethazine Hydrochloride | Promethazine Hydrochloride | Tablet | Oral | Major Pharmaceuticals | Human Prescription Drug |
10019-553 | Transderm Scop | Scopalamine | Patch, Extended Release | Transdermal | Baxter Healthcare Corporation | Human Prescription Drug |
10361-793 | E-z-gas II | Antacid/antiflatulent | Granule, Effervescent | Oral | E-z-em, Inc. | Human Otc Drug |
16714-088 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Northstar Rxllc | Human Prescription Drug |
16714-089 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Northstar Rxllc | Human Prescription Drug |
16714-090 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Northstar Rxllc | Human Prescription Drug |
16714-472 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intra-articular; Intralesional; Intramuscular; Soft Tissue | Northstar Rxllc | Human Prescription Drug |
16714-473 | Methylprednisolone Acetate | Methylprednisolone Acetate | Injection, Suspension | Intralesional; Intramuscular; Intrasynovial; Soft Tissue | Northstar Rxllc | Human Prescription Drug |
16714-981 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | Injection, Suspension | Intramuscular | Northstar Rxllc | Human Prescription Drug |
24208-539 | Miochol E | Acetylcholine Chloride | Kit | Bausch & Lomb Incorporated | Human Prescription Drug | |
27505-003 | Revonto | Dantrolene Sodium | Injection, Powder, Lyophilized, For Solution | Intravenous | Us Worldmeds, Llc | Human Prescription Drug |
32909-764 | E-z-hd | Barium Sulfate | Powder, For Suspension | Oral | E-z-em Canada Inc | Human Prescription Drug |
42023-159 | Adrenalin | Epinephrine | Injection | Intramuscular; Intravenous; Subcutaneous | Par Pharmaceutical, Inc. | Human Prescription Drug |
42023-168 | Adrenalin | Epinephrine | Injection | Intramuscular; Intravenous; Subcutaneous | Par Pharmaceutical, Inc. | Human Prescription Drug |
42023-168 | Adrenalin | Epinephrine | Injection | Intramuscular; Intravenous; Subcutaneous | Par Pharmaceutical, Inc. | Human Prescription Drug |
49502-101 | Epinephrine | Epinephrine | Injection | Intramuscular | Mylan Specialty L.p. | Human Prescription Drug |
49502-102 | Epinephrine | Epinephrine | Injection | Intramuscular | Mylan Specialty L.p. | Human Prescription Drug |
49502-500 | Epipen | Epinephrine | Injection | Intramuscular | Mylan Specialty L.p. | Human Prescription Drug |
49502-501 | Epipen Jr | Epinephrine | Injection | Intramuscular | Mylan Specialty L.p. | Human Prescription Drug |
49884-122 | Labetalol Hcl | Labetalol Hydrochloride | Tablet, Film Coated | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-123 | Labetalol Hcl | Labetalol Hydrochloride | Tablet, Film Coated | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-124 | Labetalol Hcl | Labetalol Hydrochloride | Tablet, Film Coated | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-320 | Olanzapine | Olanzapine | Tablet, Orally Disintegrating | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-321 | Olanzapine | Olanzapine | Tablet, Orally Disintegrating | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-322 | Olanzapine | Olanzapine | Tablet, Orally Disintegrating | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-323 | Olanzapine | Olanzapine | Tablet, Orally Disintegrating | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-701 | Clomiphene Citrate | Clomiphene Citrate | Tablet | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
50268-522 | Meclizine Hydrochloride | Meclizine | Tablet | Oral | Avpak | Human Prescription Drug |
50268-523 | Meclizine Hydrochloride | Meclizine Hydrochloride | Tablet | Oral | Avpak | Human Prescription Drug |
55150-111 | Ampicillin | Ampicillin Sodium | Injection, Powder, For Solution | Intramuscular; Intravenous | Eugia Us Llc | Human Prescription Drug |
55150-112 | Ampicillin | Ampicillin Sodium | Injection, Powder, For Solution | Intramuscular; Intravenous | Eugia Us Llc | Human Prescription Drug |
55150-113 | Ampicillin | Ampicillin Sodium | Injection, Powder, For Solution | Intramuscular; Intravenous | Eugia Us Llc | Human Prescription Drug |
55150-114 | Ampicillin | Ampicillin Sodium | Injection, Powder, For Solution | Intravenous | Eugia Us Llc | Human Prescription Drug |
55150-174 | Azithromycin | Azithromycin | Injection, Powder, Lyophilized, For Solution | Intravenous | Auromedics Pharma Llc | Human Prescription Drug |
59310-579 | Proair HFA | Albuterol Sulfate | Aerosol, Metered | Respiratory (inhalation) | Teva Respiratory, Llc | Human Prescription Drug |
61314-631 | Neomycin And Polymyxin B Sulfates And Dexamethasone | Neomycin And Polymyxin B Sulfates And Dexamethasone | Ointment | Ophthalmic | Sandoz Inc | Human Prescription Drug |
61314-637 | Prednisolone Acetate | Prednisolone Acetate | Suspension/ Drops | Ophthalmic | Sandoz Inc | Human Prescription Drug |
61314-656 | Ciprofloxacin Hydrochloride | Ciprofloxacin Hydrochloride | Solution/ Drops | Ophthalmic | Sandoz Inc | Human Prescription Drug |
61314-665 | Apraclonidine | Apraclonidine | Solution | Ophthalmic | Sandoz Inc | Human Prescription Drug |
62756-520 | Sumatriptan Succinate | Sumatriptan Succinate | Tablet, Film Coated | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
62756-521 | Sumatriptan Succinate | Sumatriptan Succinate | Tablet, Film Coated | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
62756-522 | Sumatriptan Succinate | Sumatriptan Succinate | Tablet, Film Coated | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
63304-614 | Doxycycline | Doxycycline | Capsule | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
63304-615 | Doxycycline | Doxycycline | Capsule | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
63304-616 | Doxycycline | Doxycycline | Capsule | Oral | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |
63323-269 | Diprivan | Propofol | Injection, Emulsion | Intravenous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-269 | Diprivan | Propofol | Injection, Emulsion | Intravenous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-481 | Xylocaine | Lidocaine Hydrochloride,epinephrine Bitartrate | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-482 | Xylocaine | Lidocaine Hydrochloride,epinephrine Bitartrate | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-483 | Xylocaine | Lidocaine Hydrochloride,epinephrine Bitartrate | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-484 | Xylocaine | Lidocaine Hydrochloride | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-485 | Xylocaine | Lidocaine Hydrochloride | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-486 | Xylocaine | Lidocaine Hydrochloride | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-487 | Xylocaine MPF | Lidocaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-488 | Xylocaine MPF | Lidocaine Hydrochloride,epinephrine Bitartrate | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-489 | Xylocaine MPF | Lidocaine Hydrochloride,epinephrine Bitartrate | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-491 | Xylocaine MPF | Lidocaine Hydrochloride | Injection, Solution | Infiltration | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-492 | Xylocaine MPF | Lidocaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-492 | Xylocaine MPF | Lidocaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-495 | Xylocaine MPF | Lidocaine Hydrochloride | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
65862-187 | Ondansetron Hydrochloride | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-187 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
65862-188 | Ondansetron Hydrochloride | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-188 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
65862-189 | Ondansetron Hydrochloride | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-189 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
67457-218 | Duraclon | Clonidine Hydrochloride | Injection, Solution | Epidural | Mylan Institutional Llc | Human Prescription Drug |
69238-1615 | Ofloxacin | Ofloxacin Otic | Solution | Auricular (otic) | Amneal Pharmaceuticals Ny Llc | Human Prescription Drug |
69238-1616 | Ofloxacin | Ofloxacin Otic | Solution | Auricular (otic) | Amneal Pharmaceuticals Ny Llc | Human Prescription Drug |
72835-502 | Elemar Patch | Lidocaine | Kit | V2 Pharma, Llc | Human Prescription Drug | |
76420-520 | Physicians Ez Use M-pred | Methylprednisolone Acetate, Bupivacaine Hydrochloride, Povidone-iodine | Kit | Epidural; Infiltration; Intramuscular; Intrasynovial; Soft Tissue; Topical | Asclemed Usa, Inc. | Human Prescription Drug |
78670-003 | Revonto | Dantrolene Sodium | Injection, Powder, Lyophilized, For Solution | Intravenous | Uswm, Llc | Human Prescription Drug |
Recall Enforcement Report D-1046-2022
Recall Enforcement Report D-1036-2022
Recall Enforcement Report D-1025-2022
Recall Enforcement Report D-1055-2022
Recall Enforcement Report D-1075-2022
Recall Enforcement Report D-0994-2022
Field Name | Field Value |
---|---|
Event ID | 89646 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-0994-2022 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | USA nationwide. What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | Miocol-E (acetylcholine chloride intraocular solution) 20 mg/2mL (10 mg/mL), Rx only, Manufacturer: Bausch & Lomb, NDC 24208-539-20 |
Reason For Recall | cGMP deviations: Temperature abuse What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 45 kits Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 06-15-2022 |
Recall Initiation Date | 04-13-2022 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Code Info | McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions. Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages | 24208-539-20 |
Status | Ongoing |
Recall Enforcement Report D-1056-2022
Recall Enforcement Report D-1018-2022
Recall Enforcement Report D-1031-2022
Recall Enforcement Report D-1079-2022
Recall Enforcement Report D-1076-2022
Recall Enforcement Report D-1022-2022
Recall Enforcement Report D-1039-2022
Recall Enforcement Report D-1120-2022
Recall Enforcement Report D-1104-2022
Recall Enforcement Report D-1099-2022
Recall Enforcement Report D-1057-2022
Recall Enforcement Report D-1013-2022
Recall Enforcement Report D-1015-2022
Recall Enforcement Report D-1081-2022
Recall Enforcement Report D-1119-2022
Recall Enforcement Report D-1059-2022
Recall Enforcement Report D-1108-2022
Recall Enforcement Report D-1008-2022
Recall Enforcement Report D-1038-2022
Recall Enforcement Report D-1103-2022
Recall Enforcement Report D-1060-2022
Recall Enforcement Report D-1117-2022
Recall Enforcement Report D-1049-2022
Recall Enforcement Report D-1020-2022
Recall Enforcement Report D-1096-2022
Recall Enforcement Report D-1118-2022
Recall Enforcement Report D-1017-2022
Recall Enforcement Report D-1094-2022
Recall Enforcement Report D-1098-2022
Recall Enforcement Report D-1106-2022
Recall Enforcement Report D-1109-2022
Recall Enforcement Report D-1054-2022
Recall Enforcement Report D-1100-2022
Recall Enforcement Report D-1063-2022
Recall Enforcement Report D-1110-2022
Recall Enforcement Report D-1080-2022
Recall Enforcement Report D-1122-2022
Recall Enforcement Report D-1010-2022
Recall Enforcement Report D-1028-2022
Recall Enforcement Report D-1061-2022
Recall Enforcement Report D-1067-2022
Recall Enforcement Report D-1007-2022
Recall Enforcement Report D-1016-2022
Recall Enforcement Report D-1005-2022
Recall Enforcement Report D-1030-2022
Recall Enforcement Report D-1004-2022
Recall Enforcement Report D-1003-2022
Recall Enforcement Report D-1114-2022
Recall Enforcement Report D-1047-2022
Recall Enforcement Report D-1066-2022
Recall Enforcement Report D-1070-2022
Recall Enforcement Report D-1111-2022
Recall Enforcement Report D-1064-2022
Recall Enforcement Report D-1089-2022
Recall Enforcement Report D-1097-2022
Recall Enforcement Report D-1000-2022
Recall Enforcement Report D-1107-2022
Recall Enforcement Report D-1032-2022
Recall Enforcement Report D-1026-2022
Recall Enforcement Report D-1045-2022
Recall Enforcement Report D-1073-2022
Recall Enforcement Report D-1006-2022
Recall Enforcement Report D-1065-2022
Recall Enforcement Report D-1105-2022
Recall Enforcement Report D-1050-2022
Recall Enforcement Report D-1115-2022
Recall Enforcement Report D-1021-2022
Recall Enforcement Report D-1002-2022
Recall Enforcement Report D-1091-2022
Recall Enforcement Report D-1040-2022
Recall Enforcement Report D-1001-2022
Recall Enforcement Report D-1029-2022
Recall Enforcement Report D-0996-2022
Recall Enforcement Report D-1116-2022
Recall Enforcement Report D-1121-2022
Recall Enforcement Report D-1043-2022
Recall Enforcement Report D-1077-2022
Recall Enforcement Report D-1113-2022
Recall Enforcement Report D-1033-2022
Recall Enforcement Report D-1083-2022
Recall Enforcement Report D-1101-2022
Recall Enforcement Report D-1034-2022
Recall Enforcement Report D-1014-2022
Recall Enforcement Report D-1102-2022
Recall Enforcement Report D-1044-2022
Recall Enforcement Report D-0995-2022
Recall Enforcement Report D-1019-2022
Recall Enforcement Report D-1086-2022
Recall Enforcement Report D-0999-2022
Recall Enforcement Report D-1058-2022
Recall Enforcement Report D-1062-2022
Recall Enforcement Report D-0998-2022
Recall Enforcement Report D-1090-2022
Recall Enforcement Report D-1011-2022
Recall Enforcement Report D-1082-2022
Recall Enforcement Report D-1024-2022
Recall Enforcement Report D-0997-2022
Recall Enforcement Report D-1078-2022
Recall Enforcement Report D-1035-2022
Recall Enforcement Report D-1093-2022
Recall Enforcement Report D-1041-2022
Recall Enforcement Report D-1068-2022
Recall Enforcement Report D-1027-2022
Recall Enforcement Report D-1087-2022
Recall Enforcement Report D-1042-2022
Recall Enforcement Report D-1072-2022
Recall Enforcement Report D-1084-2022
Recall Enforcement Report D-1095-2022
Recall Enforcement Report D-1112-2022
Recall Enforcement Report D-1069-2022
Recall Enforcement Report D-1052-2022
Field Name | Field Value |
---|---|
Event ID | 89646 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-1052-2022 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | USA nationwide. What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | Xylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL, 25-count box (NDC 63323-482-57), Rx only, MFG: Fresenius Kabi USA LLC |
Reason For Recall | cGMP deviations: Temperature abuse What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 76 trays/25 vials per tray Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 06-15-2022 |
Recall Initiation Date | 04-13-2022 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Code Info | McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages | 63323-492-04; 63323-492-27; 63323-492-09; 63323-492-57; 63323-492-07; 63323-492-37; 63323-492-03; 63323-492-31; 63323-491-01; 63323-491-57; 63323-495-09; 63323-495-27; 63323-495-04; 63323-495-07; 63323-485-01; 63323-485-27; 63323-485-03; 63323-485-57; 63323-486-01; 63323-486-17; 63323-486-02; 63323-486-27; 63323-486-05; 63323-486-57; 63323-484-57; 63323-489-02; 63323-489-27; 63323-489-03; 63323-489-21; 63323-489-01; 63323-489-17; 63323-488-07; 63323-488-37; 63323-488-03; 63323-488-31; 63323-488-01; 63323-488-17; 63323-481-01; 63323-481-57; 63323-483-03; 63323-483-27; 63323-483-01; 63323-483-57; 63323-482-01; 63323-482-17; 63323-482-03; 63323-482-27; 63323-482-05; 63323-482-57; 63323-487-01; 63323-487-17; 63323-487-07; 63323-487-37; 63323-487-03; 63323-487-31 |
Status | Ongoing |
Recall Enforcement Report D-1085-2022
Recall Enforcement Report D-1037-2022
Recall Enforcement Report D-1051-2022
Recall Enforcement Report D-1023-2022
Recall Enforcement Report D-1092-2022
Recall Enforcement Report D-1053-2022
Field Name | Field Value |
---|---|
Event ID | 89646 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-1053-2022 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | USA nationwide. What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27 |
Reason For Recall | cGMP deviations: Temperature abuse What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 33 trays/25 vials per tray Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 06-15-2022 |
Recall Initiation Date | 04-13-2022 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Code Info | McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages | 63323-492-04; 63323-492-27; 63323-492-09; 63323-492-57; 63323-492-07; 63323-492-37; 63323-492-03; 63323-492-31; 63323-491-01; 63323-491-57; 63323-495-09; 63323-495-27; 63323-495-04; 63323-495-07; 63323-485-01; 63323-485-27; 63323-485-03; 63323-485-57; 63323-486-01; 63323-486-17; 63323-486-02; 63323-486-27; 63323-486-05; 63323-486-57; 63323-484-57; 63323-489-02; 63323-489-27; 63323-489-03; 63323-489-21; 63323-489-01; 63323-489-17; 63323-488-07; 63323-488-37; 63323-488-03; 63323-488-31; 63323-488-01; 63323-488-17; 63323-481-01; 63323-481-57; 63323-483-03; 63323-483-27; 63323-483-01; 63323-483-57; 63323-482-01; 63323-482-17; 63323-482-03; 63323-482-27; 63323-482-05; 63323-482-57; 63323-487-01; 63323-487-17; 63323-487-07; 63323-487-37; 63323-487-03; 63323-487-31 |
Status | Ongoing |
Recall Enforcement Report D-1048-2022
Recall Enforcement Report D-1088-2022
Recall Enforcement Report D-1009-2022
Recall Enforcement Report D-0993-2022
Field Name | Field Value |
---|---|
Event ID | 89646 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-0993-2022 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | USA nationwide. What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02 |
Reason For Recall | cGMP deviations: Temperature abuse What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 5 cartons Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 06-15-2022 |
Recall Initiation Date | 04-13-2022 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Code Info | McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions. Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages | 49502-500-01; 49502-500-02; 49502-500-92; 49502-501-01; 49502-501-02; 49502-501-92 |
Status | Ongoing |